{
    "root": "4fa51e7c-c82d-4fbb-bb58-c2664eebd262",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "EOVIST",
    "value": "20250305",
    "ingredients": [
        {
            "name": "GADOXETATE DISODIUM",
            "code": "HOY74VZE0M"
        },
        {
            "name": "TROMETHAMINE",
            "code": "023C2WHX2V"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "eovist indicated intravenous magnetic resonance imaging ( mri ) liver detect characterize lesions patients known suspected focal liver disease .",
    "contraindications": "• recommended dose 0.1 ml/kg body weight ( 2.1 ) • administer intravenous injection recommended rate 1 ml 2 ml per second ( 2.2 ) • follow injection normal saline flush ( 2.2 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "eovist contraindicated patients history severe hypersensitivity eovist [ ( 5.3 ) ] .",
    "indications_original": "EOVIST is indicated for intravenous use in magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in patients with known or suspected focal liver disease.",
    "contraindications_original": "• Recommended dose is 0.1 mL/kg body weight ( 2.1 ) • Administer as an intravenous injection at a recommended rate of 1 mL to 2 mL per second ( 2.2 ) • Follow injection with a normal saline flush ( 2.2 )",
    "adverseReactions_original": "EOVIST is contraindicated in patients with history of severe hypersensitivity reactions to EOVIST [see Warnings and Precautions (\n                     \n                        5.3\n                     \n                     )]."
}